
Overview
Dr. Justine Kahn is a Pediatric Oncologist and a clinical investigator specializing in survival outcomes, cancer care delivery, and health equity in children and adolescent/young adults (AYA) with Hodgkin lymphoma, non-Hodgkin lymphoma, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Dr. Kahn received her MD from the Icahn School of Medicine at Mount Sinai in New York and completed her Pediatric Residency at Mount Sinai Kravis Children’s Hospital in New York. Dr. Kahn completed her Clinical Fellowship in Pediatric Hematology/Oncology at Columbia University Medical Center. While in residency, Dr. Kahn was elected to Alpha Omega Alpha, the national medical honor society which recognizes high educational achievement. During her fellowship, Dr. Kahn served as a Postdoctoral Research Fellow in Cancer-Related Population Sciences supported by the National Cancer Institute for her work in cancer care delivery, health equity, and health outcomes research. Upon graduation from fellowship, Dr. Kahn joined the Pediatric Hematology/Oncology Division at Columbia University Medical Center as an Oncology Instructor and Attending Physician in 2016. She is currently involved in patient care, clinical trials research, and health outcomes research. In June of 2018, Dr. Kahn obtained a Master of Science in Patient Oriented Research at the Columbia Mailman School of Public Health. In July of 2018 she became an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology/Stem Cell Transplantation.Dr. Kahn is actively conducting research through studies developed in the Dana-Farber Cancer Institute (DFCI) ALL Consortium, the Children's Oncology Group (COG), and at Columbia University. Columbia boasts a strong commitment to health disparities research in one of the most diverse patient populations in the United States. Dr. Kahn has chosen to focus her research efforts on underserved populations because studies suggest that poor access-to-care, low health literacy, and financial stress can all negatively impact survival in children and AYAs with cancer. Dr. Kahn is supported in part by the Lymphoma Research Foundation and recently received an institutional Career Development Award for her ongoing work on survival disparities in children and AYAs with Hodgkin lymphoma. She serves as CUMC site Principal Investigator for the DFCI ALL Consortium.
Dr. Kahn is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration.
Dr. Kahn is board certified in Pediatrics and Pediatric Hematology-Oncology. She is actively involved in clinical research, co-authoring 61 peer reviewed articles and participating in 37 clinical trials. Dr. Kahn is currently accepting new patients.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
161 Fort Washington Avenue, New York, NY 10032
Additional Areas of Focus
Dr. Kahn has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
37 Clinical Trials
Cardiology Consultants
Mitchell Cairo is a Pediatrics provider practicing medicine in Hawthorne, New York. Dr. Cairo is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Burkitt Lymphoma, Primary Mediastinal B-Cell Lymphoma (PMBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Transplant.
The Children's Hospital At Montefiore
Melissa Wasserstein is a Pediatrics provider practicing medicine in Bronx, New York. Dr. Wasserstein is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Acid Sphingomyelinase Deficiency (ASMD), Niemann-Pick Disease, Reticulohistiocytoma, and Splenomegaly.
Young Adult Institute Inc
Steven Wolf is a Pediatrics provider practicing medicine in New York, New York. Dr. Wolf is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Lennox-Gastaut Syndrome (LGS), Epilepsy, Seizures, Thrombectomy, and Deep Brain Stimulation.
Frequently Asked Questions about Dr. Justine Kahn
How do I make an appointment with Dr. Justine Kahn?
You can book an appointment with Dr. Justine Kahn by calling their office at 212-305-9770. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Justine Kahn a top-rated expert for Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Justine Kahn is classified as an Distinguished expert for Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Justine Kahn specialize in?
While Dr. Justine Kahn is a Pediatrics, they have specific expertise in Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), and Leukemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.
Does Dr. Justine Kahn participate in research or clinical trials?
Yes. Dr. Justine Kahn has published 61 articles and abstracts on conditions like Hodgkin Lymphoma. You can view a list of Dr. Justine Kahn's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Justine Kahn accept my insurance?
Dr. Justine Kahn accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-305-9770 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Hodgkin LymphomaDr. Kahn isDistinguished. Learn about Hodgkin Lymphoma.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Denys-Drash Syndrome (DDS)Dr. Kahn isAdvanced. Learn about Denys-Drash Syndrome (DDS).
- HepatoblastomaDr. Kahn isAdvanced. Learn about Hepatoblastoma.
- HistiocytosisDr. Kahn isAdvanced. Learn about Histiocytosis.
- IntersexDr. Kahn isAdvanced. Learn about Intersex.
- Langerhans Cell HistiocytosisDr. Kahn isAdvanced. Learn about Langerhans Cell Histiocytosis.
- Experienced
- Acute Monoblastic Leukemia (AmoL)Dr. Kahn isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Adult Soft Tissue SarcomaDr. Kahn isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Aplastic AnemiaDr. Kahn isExperienced. Learn about Aplastic Anemia.
- Bone Marrow AspirationDr. Kahn isExperienced. Learn about Bone Marrow Aspiration.
- Embryonal Tumor with Multilayered Rosettes
- Ewing SarcomaDr. Kahn isExperienced. Learn about Ewing Sarcoma.


